Medspa Equipment & Startup Financing in Austin, Texas (2026 Guide)

Scan the situations below, pick the one that matches where your Austin practice stands right now, and go straight to that guide—each one covers rates, terms, lender picks, and application steps for that specific scenario.

What to know before you choose a path

Medspa equipment financing and aesthetic practice startup loans look similar on the surface but split into meaningfully different products once you look at the numbers. Here's how to orient yourself.

Who each option fits

• Equipment financing (laser devices, RF platforms, body-contouring systems): The device itself serves as collateral, which is why lenders can move fast—approval in 1–3 days is common. Rates for practices with a FICO of 700+ run 7–11% APR. Fair-credit borrowers (620–679) pay roughly 2–4 percentage points more. Most lenders ask for 10–20% down, though some specialty aesthetic lenders will go to zero-down for strong applicants. If you're financing a $150,000–$250,000 laser platform, this is almost always the first path to price out.

• SBA 7(a) loans: The right tool when you need to bundle equipment, leasehold improvements, working capital, and possibly a practice buyout into one loan. The 2026 rate range is 8.5–11% APR, terms go up to 10 years on equipment and working capital, and the maximum is $5,000,000. The tradeoff: you need at least 24 months in business, a minimum FICO of 640, and approval takes 30–45 days. Austin's strong SBA lending ecosystem—several preferred lenders operate here—shortens that timeline somewhat compared to smaller Texas markets.

• Working capital loans and lines of credit: These cover injectable inventory (Botox, fillers, biostimulators), marketing pushes, and payroll gaps between slow and peak months. Expect 8.5–11% APR from bank and SBA-backed lines; merchant cash advances are fast but carry APR-equivalent costs of 25–80%+, so reserve them for genuine short-term gaps. Lenders will review 12 months of bank statements and want your monthly debt service to stay under 45–50% of gross revenue.

• Startup loans (under 2 years in business): The hardest category because SBA and most bank products require an operating history. Alternatives include equipment-only financing (the device collateralizes itself), SBA Microloans up to $50,000 for early-stage needs, CDFI loans through Austin's small-business lending network, and practice-specific lenders who underwrite on the owner's clinical credentials and projected revenue rather than history alone.

The concrete numbers that separate these paths

Scenario	Typical rate	Down payment	Approval time
Equipment loan, 700+ FICO	7–11% APR	10–20%	1–3 days
SBA 7(a), established practice	8.5–11% APR	10–20%	30–45 days
Working capital line	8.5–11% APR	None	1–5 days
Merchant cash advance	25–80%+ APR equiv.	None	1–2 days
SBA Microloan (startup)	Varies by intermediary	None–10%	2–4 weeks

What trips people up

The biggest mistake Austin medspa owners make is treating every financing product as interchangeable. A 12-month equipment lease that lets you upgrade to the next-generation laser platform every cycle is a fundamentally different decision from a 10-year SBA loan on the same device—especially when the Section 179 expensing deduction (capped at $1,220,000 in 2026) only applies to purchases, not true leases. Similarly, practitioners sometimes stack a working capital loan on top of an equipment loan without modeling debt service—lenders cap total monthly payments at roughly 45–50% of revenue, and that ceiling gets hit faster than expected when you're carrying multiple notes.

Austin's medspa market is competitive enough that being under-capitalized at launch costs more in lost revenue than the interest on a well-structured loan. Practices in comparable Texas markets—Arlington and Amarillo among them—face the same equipment costs but different competitive pressures, so local market context matters when sizing your loan.

Aesthetic inventory—particularly Botox and filler stock—has its own financing logic separate from hard equipment. Botox supply chain financing in Austin covers the cash-flow cycle for injectable stock specifically, since that inventory turns on a different timeline than capital equipment. For practices combining an SBA loan with equipment financing, SBA loan structuring for medspas lays out how to package multiple needs into a single application without over-leveraging.

Origination fees on most equipment and SBA products run 1–3% of the loan amount—factor that into your true cost of capital alongside the stated rate before comparing lender offers.